SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States
Jun 1, 2024, 00:00
10.1016/j.jval.2024.03.1876
https://www.valueinhealthjournal.com/article/S1098-3015(24)01991-0/fulltext
Title :
SA29 Motivations and Barriers for Psychiatric Practice Adoption of Esketamine Nasal Spray for Treatment-Resistant Depression in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)01991-0&doi=10.1016/j.jval.2024.03.1876
First page :
Section Title :
Open access? :
No
Section Order :
11531